Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2023-07-27 Capital/Financing Update
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
금전대여결정
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (Nexturn Bio) detailing a 'Decision on Money Lending' (금전대여결정). This is a specific type of corporate disclosure regarding financial transactions between a company and its subsidiary. Since it does not fit into specific categories like dividends, M&A, or earnings releases, and is a standard regulatory disclosure required by the exchange, it falls under the 'Regulatory Filings' category.
2023-07-27 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a paid-in capital increase (유상증자결정) and a subsequent correction (정정신고) for Nexturn Bioscience. This document details the issuance of new shares, pricing, and allocation, which falls under the category of share issuance and capital changes. According to the provided definitions, announcements regarding new share issues or capital changes are classified as 'SHA'.
2023-07-27 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a '소액공모공시서류(지분증권) 정정신고' (Small-scale Public Offering Disclosure Document - Amendment) filed by Nexturn Bioscience. It details changes to the subscription schedule, payment dates, and listing dates for a third-party allocation capital increase. This type of filing is a regulatory requirement for small-scale offerings in South Korea, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Share Issue/Capital Change' (which usually refers to larger, standard capital changes) or 'Annual Report'.
2023-07-27 Korean
타법인주식및출자증권취득결정(자율공시)(종속회사의주요경영사항)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Nexturn BIO) regarding the acquisition of shares/equity in another entity (a new technology investment fund). This type of disclosure, which details a specific corporate transaction (investment/acquisition), is classified as a general regulatory filing (RNS) as it does not fit into specific categories like M&A (which usually implies a takeover or merger of a business entity) or capital raising (it is an investment by the company).
2023-07-27 Korean
타법인주식및출자증권취득결정(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Nexturn Bio regarding the acquisition of shares in another company (타법인주식및출자증권취득결정). This is a specific corporate action announcement detailing the investment, the target company, the acquisition amount, and the purpose of the investment. Since it does not fit into specific categories like M&A (which usually implies a merger or takeover of a business entity rather than a portfolio investment) or share issuance, it falls under the general regulatory filing category for corporate disclosures.
2023-07-27 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a '소액공모공시서류(지분증권) 정정신고' (Correction Report for Small-Scale Public Offering of Equity Securities). It details changes to the issuance price, number of shares, and total offering amount for a third-party allocation capital increase. Since this is a formal regulatory filing regarding a capital change/share issuance that does not fit into the other specific categories like '10-K' or 'ER', and it is a primary regulatory document rather than a mere announcement of a report, it is classified as a Regulatory Filing (RNS).
2023-07-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.